Literature DB >> 2789935

Critical evaluation of histochemical and immunochemical methods for the demonstration of vascular supply in rectal and oesophageal cancer.

R Porschen1, C Langen, A Kriegel, B Lohe, F Borchard.   

Abstract

The vascularisation of rectal and oesophageal carcinomas and of normal mucosa was studied using histochemical and immunohistochemical methods. Endothelial cells were stained for alkaline phosphatase (AP) using an azo-dye procedure. Histochemical results were compared with the immunohistochemical identification of endothelial cells using the monoclonal antibody BW 200 recognising an epitope restricted to human endothelial cells. In the AP experiments the simultaneous reactivity of stromal tissue often precluded the exact evaluation of tumour blood vessels. Immunohistochemistry facilitated the identification of vessels in neoplastic tissues and allowed a quantitative analysis of vascular volume by means of point-counting. Vascular volumes of normal tissues exceeded those of tumours by a factor of 1.6. This immunohistochemical technique has potential application in studying the importance of tumour blood supply in man, especially in relation to radiotherapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789935      PMCID: PMC2247169          DOI: 10.1038/bjc.1989.274

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Immunohistochemical and immunochemical characterization of a new endothelial cell-specific antigen.

Authors:  J U Alles; K Bosslet
Journal:  J Histochem Cytochem       Date:  1986-02       Impact factor: 2.479

2.  Identification of vessels by lectin-immunoperoxidase staining of endothelium: possible applications in urogenital malignancies.

Authors:  M Fujime; C W Lin; G R Prout
Journal:  J Urol       Date:  1984-03       Impact factor: 7.450

3.  Monoclonal antibody PAL-E specific for endothelium.

Authors:  R O Schlingemann; G M Dingjan; J J Emeis; J Blok; S O Warnaar; D J Ruiter
Journal:  Lab Invest       Date:  1985-01       Impact factor: 5.662

4.  Carcinoma-specific Ulex europaeus agglutinin-I binding glycoproteins of human colorectal carcinoma and its relation to carcinoembryonic antigen.

Authors:  Y Matsushita; S Yonezawa; T Nakamura; S Shimizu; M Ozawa; T Muramatsu; E Sato
Journal:  J Natl Cancer Inst       Date:  1985-08       Impact factor: 13.506

5.  Vascular density in carcinoma of the uterine cervix and its predictive value for radiotherapy.

Authors:  E Siracká; L Révész; R Kovác; J Siracký
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

6.  A rapid and simple immunoperoxidase staining procedure for blood and bone marrow samples.

Authors:  U Köller; H Stockinger; O Majdic; P Bettelheim; W Knapp
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

7.  Growth and vascular structure of human melanoma xenografts.

Authors:  E K Rofstad
Journal:  Cell Tissue Kinet       Date:  1984-01

8.  Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.

Authors:  H Holthöfer; I Virtanen; A L Kariniemi; M Hormia; E Linder; A Miettinen
Journal:  Lab Invest       Date:  1982-07       Impact factor: 5.662

9.  Measurement of the grade of vascularisation in histological tumour tissue sections.

Authors:  M L Mlynek; D van Beunigen; L D Leder; C Streffer
Journal:  Br J Cancer       Date:  1985-12       Impact factor: 7.640

10.  Vascular structure of five human malignant melanomas grown in athymic nude mice.

Authors:  O V Solesvik; E K Rofstad; T Brustad
Journal:  Br J Cancer       Date:  1982-10       Impact factor: 7.640

View more
  2 in total

1.  Microvascular structure of benign and malignant tumors of the colon in humans.

Authors:  S A Skinner; G M Frydman; P E O'Brien
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

2.  Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.

Authors:  P B Vermeulen; D Verhoeven; H Fierens; G Hubens; G Goovaerts; E Van Marck; E A De Bruijn; A T Van Oosterom; L Y Dirix
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.